On August 8, Beijing attorney Yi Shenghua made an online disclosure of case materials related to the theft, insult, and intentional destruction of human corpses, triggering a media frenzy in China. The alleged company involved in such activity is Shanxi Aorui Biological Materials Co., Ltd. (Shanxi Aorui), established in 1999 as a subsidiary of the state-owned China Radiation Protection Research Institute. The company’s business scope consists of research, development, production, and sale of “allogeneic bone implantation materials.” The company is accused of illegally purchasing corpses and limbs and then engaging in brutal dissection, removal of flesh, cleaning, irradiation, etc., of these bodies and bones, to produce “allogeneic bone implantation materials” during the time period from January 2015 through July 2023. The company had a total revenue of 380 million yuan (US$ 53 million) from the period 2015 through 2023.
Allogeneic bones (from humans) are a good source of material for bone transplantation and, per established international medical standards, should come from explicit donors. Shanxi Aorui’s sources generally did not sign up to be donors, and the family members of the deceased were not aware of the Shanxi Aorui activities.
There are currently 75 criminal suspects identified; all have confessed to criminal activities consistent with the allegations against Shanxi Aorui. The business conducted operations in Chongqing City and provinces of Sichuan, Guangxi, Shandong, Guizhou, and Yunnan.
Frighteningly, the case is linked to China’s live organ transplant industry. Qingdao University Affiliated Hospital is one of the hospitals designated by the Ministry of Health for performance of liver transplants. Between 2015 and 2021, the hospital’s Associate Chief Physician Li Zhiqiang at the Liver Disease Center dismembered organ donor corpses and stored them in a freezer before selling them to Shanxi Aorui, with each corpse fetching a price between 10,000 and 22,000 yuan. Shanxi Aorui picked up five deliveries from Li. The hospital’s website listed Li as the Deputy Director of the Organ Transplant Center and Director of the Intensive Care Unit. After the incident gained attention, the hospital removed Li’s resume from its website.
Source: Epoch Times, August 8, 2024
https://www.epochtimes.com/gb/24/8/8/n14307307.htm